Pattern recognition receptors and their role in immunopathogenesis of pneumonia
https://doi.org/10.15789/1563-0625-PRR-3328
Abstract
Non-specific binding of antigens is provided by the so-called pattern recognition receptors (PRR) that may be located on the cell membrane, in the cytosol, or, as soluble molecules in the blood serum. Membrane receptors include: Toll-like receptors, C-type lectin receptors, scavenger receptors. TLR, NOD-like receptors, RIG-I-like receptors, AIM-2-like receptors are located in the cytosol. Soluble receptors include pentraxins, collectins, and ficolins. After entering a microorganism to lung spaces, the non-specific defense factors and innate immunity mechanisms are primarily involved in the immune response. If non-specific recognition of pathogens is ineffective, a pneumonia focus is formed. In this regard, the role of PRR in the development of community-acquired pneumonia is quite significant. To search for literature appropriate publications, an analysis of the research databases Scopus, Web of Science, Pubmed, CyberLeninka, and RINC was conducted. The studies have demonstrated the importance of TLR4 in combating both Gram-positive and Gram-negative microorganisms. In addition, the blood levels of sCD206 lectin receptor have been considered a predictor of severe pneumonia and lethal outcomes. Increased production of a CD5-like scavenger receptor was observed in pneumonia caused by S.aureus. NOD-like receptors play an important role in defense against Acinetobacter baumannii. Pentraxins perform many functions: they exhibit opsonic properties, activate complement via the classical pathway, activate neutrophils, and regulate chemotaxis and apoptosis. In adult patients with pneumonia, elevated blood CRP levels correspond to disease severity; measurement of CRP levels helps differentiate pneumonia from other acute respiratory infections. PTX3 is a factor that can help determine the severity and prognosis of pneumonia. Mannane-binding lectin (MBL) recognizes bacterial lipopolysaccharides (LPS) in capsular layer, or cell wall of Gram-negative bacteria, lipoarabinomannans, fungal mannans, SARSCoV-2 glycoproteins, PAMP of protozoa and helminths. Ficolins interact with viral, bacterial and fungal antigens. L-ficolin recognizes pneumococcal pneumolysin, activates complement via the lectin pathway, thereby neutralizing the toxin. Thus, a critical role of innate immunity factors in pathogenesis of pneumonia is well proven but requires further research. Studying the mechanisms of disease immunopathogenesis will allow development of new prognostic models and improve the efficiency of therapy, especially in severe cases of pneumonia.
About the Authors
M. O. ZolotovRussian Federation
Maxim O. Zolotov - PhD (Medicine), Associate Professor, Department of Medical Microbiology and Immunology; Head, Laboratory of Translational Technologies and Interdisciplinary Relations at the Professional Center for Education and Research in Genetic and Laboratory Technologies
20 Gagarin St Samara 443079
N. B. Migacheva
Russian Federation
PhD, MD (Medicine), Associate Professor, Head, Department of Pediatrics
Samara
A. V. Lyamin
Russian Federation
PhD, MD (Medicine), Associate Professor, Professor, Department of Medical Microbiology and Immunology; Director, Professional Center for Education and Research in Genetic and Laboratory Technologies
Samara
References
1. Budanova E.V., Svitich O.A., Shulenina E.A., Zverev V.V. Association of TLR2, TLR4, TLR9 gene expression related to innate immunity with in vivo acute respiratory infections caused by Klebsiella pneumoniae. Meditsinskaya immunologiya = Medical Immunology (Russia), 2018, Vol. 20, no. 3, pp. 425-430. (In Russ.) doi: 10.15789/1563-0625-2018-3-425-430.
2. Community-acquired pneumonia in adults: Clinical guidelines of the Ministry of Health of the Russian Federation [Electronic resource]. Moscow, 2024. 135 p. Available at: https://cr.minzdrav.gov.ru/viewcr/654_2.
3. Minakov A.A., Vakhlevskii V.V., Voloshin N.I., Kharitonov M.A., Salukhov V.V., Tyrenko V.V., Rudakov V.Yu., Vakhlevskaya E.N., Alekhina E.V. Modern view on the etiology and immunological aspects of pneumonia. Meditsinskiy sovet = Medical Council, 2023, Vol. 17, no. 4, pp. 141-153. (In Russ.)
4. Mischenko A.A. Transmembrane C-type lectin receptors in immunity. Vestnik Syktyvkarskogo universiteta. Seriya 2: Yestestvoznaniye. Meditsina = Syktyvkar University Bulletin. Series 2: Natural Science. Medicine, 2021, Vol. 4, no. 20, pp. 8-21. (In Russ.)
5. Saidov M.Z. DAMP-mediated inflammation and regulated cell death in immunoinflammatory rheumatic diseases. Meditsinskaya immunologiya = Medical Immunology (Russia), 2023, Vol. 25, no. 1, pp. 7-38. (In Russ.) doi: 10.15789/1563-0625-DMI-2557.
6. Smolnikova M.V., Tereshchenko S.Yu. Proteins of the lectin pathway of the complement system activation: immunobiological functions, genetics and involvement in the pathogenesis of human diseases. Infektsiya i immunitet = Russian Journal of Infection and Immunity, 2022, Vol. 12, no. 2, pp. 209–221. (In Russ.) doi: 10.15789/2220-7619-POT-1777.
7. Tereshchenko S.Yu., Smolnikova M.V. Congenitally impaired pattern-recognition receptors in pathogenesis of pediatric invasive and recurrent pneumococcal infection. Infektsiya i immunitet = Russian Journal of Infection and Immunity, 2019, Vol. 9, no. 2, pp. 229-238. (In Russ.) doi: 10.15789/2220-7619-2019-2-229-2387.
8. Aabenhus R., Jensen J.U., Jørgensen K.J., Hróbjartsson A., Bjerrum L. Biomarkers as point-of-care tests to guide prescription of antibiotics in patients with acute respiratory infections in primary care. Cochrane Database Syst. Rev., 2022, no. 10, CD010130. doi: 10.1002/14651858.CD010130.pub3.
9. Alay H., Laloglu E. The role of angiopoietin-2 and surfactant protein-D levels in SARS-CoV-2-related lung injury: A prospective, observational, cohort study. J. Med. Virol., 2021, Vol. 93, no. 10, pp. 6008-6015.
10. Ali Y.M., Kenawy H.I., Muhammad A., Sim R.B., Andrew P.W., Schwaeble W.J. Human L-ficolin, a recognition molecule of the lectin activation pathway of complement, activates complement by binding to pneumolysin, the major toxin of Streptococcus pneumoniae. PLoS ONE, 2013, Vol. 8, no. 12, e82583. doi: 10.1371/journal.pone.0082583
11. Bist P., Dikshit N., Koh T.H., Mortellaro A., Tan T.T., Sukumaran B. The Nod1, Nod2, and Rip2 axis contributes to host immune defense against intracellular Acinetobacter baumannii infection. Infect. Immun., 2014, Vol. 82, no. 3, pp. 1112-1122.
12. Brisse M., Ly H. Comparative Structure and Function Analysis of the RIG-I-Like Receptors: RIG-I and MDA5. Front. Immunol., 2019, no. 10, 1586. doi: 10.3389/fimmu.2019.01586.
13. Britton N., Kitsios G., Fitch A., Methe B., Mcverry B., Morris A. Diversity of the lung mycobiome is associated with severity of disease in acute respiratory distress syndrome. Eur. Respir. J., 2020, no. 56 (Suppl. 64), 3722. doi: 10.1183/13993003.congress-2020.3722.
14. Cai X., Fu Y., Chen Q. Association between TLR4 A299G polymorphism and pneumonia risk: a metaanalysis. Med. Sci. Monit., 2015, no. 21, pp. 625-629.
15. Cedzyński M., Świerzko A.S. Collectins and ficolins in neonatal health and disease. Front. Immunol., 2023, Vol. 14, 1323797. doi: 10.3389/fimmu.2023.1323797
16. Chalmers J.D., Fleming G.B., Rutherford J., Matsushita M., Kilpatrick D.C., Hill A.T. Serum ficolin-2 in hospitalised patients with community-acquired pneumonia. Inflammation, 2014, Vol. 37, no. 5, pp. 1635-1641.
17. Chu Y.T., Liao M.T., Tsai K.W., Lu K.C., Hu W.C. Interplay of Chemokines Receptors, Toll-like Receptors, and Host Immunological Pathways. Biomedicines, 2023, Vol. 11, no. 9, 2384. doi: 10.3390/biomedicines11092384.
18. Cummings R.D., Chiffoleau E., van Kooyk Y., McEver R.P. C-Type Lectins. In: Varki A., Cummings R.D., Esko J.D., Stanley P., Hart G.W., Aebi M., Mohnen D., Kinoshita T., Packer N.H., Prestegard J.H., Schnaar R.L., Seeberger P.H. (eds.). Essentials of Glycobiology. 4th ed. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 2022. Chapter 34. Available at: https://www.ncbi.nlm.nih.gov/books/NBK579916/.
19. Deng Y.P., Sun J., He Q.Y., Liu Y., Fu L., Zhao H. The value of surfactant protein a in evaluating the severity and prognosis in community-acquired pneumonia patients. BMC Pulm. Med., 2024, Vol. 24, no. 1, 472. doi: 10.1186/s12890-024-03297-y.
20. Ding J., Liu Q. Toll-like receptor 4: A promising therapeutic target for pneumonia caused by Gram-negative bacteria. J. Cell. Mol. Med., 2019, Vol., 23, no. 9, pp. 5868-5875.
21. Drouin M., Saenz J., Chiffoleau E. C-type lectin-like receptors: head or tail in cell death immunity. Front. Immunol., 2020, no. 11, 251. doi: 10.3389/fimmu.2020.00251.
22. Ebell M.H., Bentivegna M., Cai X., Hulme C., Kearney M. Accuracy of biomarkers for the diagnosis of adult community-acquired pneumonia: a meta-analysis. Acad. Emerg. Med., 2020, Vol. 27, no. 3, pp. 195-206.
23. Endeman H., Herpers B.L., de Jong B.A.W., Voorn G.P., Grutters J.C., van Velzen-Blad H., Biesma D.H. Mannose-binding lectin genotypes in susceptibility to community-acquired pneumonia. Chest, 2008, Vol. 134, no. 6, pp. 1135-1140.
24. Endo Y., Takahashi M., Iwaki D., Ishida Y., Nakazawa N., Kodama T., Matsuzaka T., Kanno K., Liu Y., Tsuchiya K., Kawamura I., Ikawa M., Waguri S., Wada I., Matsushita M., Schwaeble W.J., Fujita T. Mice deficient in ficolin, a lectin complement pathway recognition molecule, are susceptible to Streptococcus pneumoniae infection. J. Immunol., 2012, Vol. 189, no. 12, pp. 5860-5866.
25. Florin T.A., Ambroggio L., Brokamp C., Zhang Y., Rattan M., Crotty E., Belsky M.A., Krueger S., Epperson 4th T.N., Kachelmeyer A., Ruddy R., Shah S.S. Biomarkers and disease severity in children with community-acquired pneumonia. Pediatrics, 2020, Vol. 146, no. 3, e2020011452. doi: 10.1542/peds.2020-011452.
26. Gao X., Yan X., Zhang Q., Yin Y., Cao J. CD5L contributes to the pathogenesis of methicillin-resistant Staphylococcus aureus-induced pneumonia. Int. Immunopharmacol., 2019, no. 72, pp. 40-47.
27. García-Laorden M.I., Rodríguez de Castro F., Solé-Violán J., Rajas O., Blanquer J., Borderías L., Aspa J., Briones M.L., Saavedra P., Marcos-Ramos J.A., González-Quevedo N., Sologuren I., Herrera-Ramos E., Ferrer J.M., Rello J., Rodríguez-Gallego C. Influence of genetic variability at the surfactant proteins A and D in communityacquired pneumonia: a prospective, observational, genetic study. Crit. Care, 2011, Vol. 15, no. 1, R57. doi: 10.1186/cc10030.
28. Geyer C.E., Mes L., Newling M., den Dunnen J., Hoepel W. Physiological and Pathological Inflammation Induced by Antibodies and Pentraxins. Cells, 2021, Vol. 10, no. 5, 1175. doi: 10.3390/cells10051175.
29. Gonzalez O.A., Kirakodu S., Novak M.J., Stromberg A.J., Orraca L., Gonzalez-Martinez J., Burgos A., Ebersole J.L. Comparative analysis of microbial sensing molecules in mucosal tissues with aging. Immunobiology, 2018, no. 223, pp. 279-287.
30. Gromelsky Ljungcrantz E., Askman S., Sjövall F., Paulsson M. Biomarkers in lower respiratory tract samples in the diagnosis of ventilator-associated pneumonia: a systematic review. Eur. Respir. Rev., 2025, Vol. 34, no. 176, 240229. doi: 10.1183/16000617.0229-2024.
31. Hollwedel F.D., Maus R., Stolper J., Khan A., Stocker B.L, Timmer M.S.M., Lu X., Pich A., Welte T., Yamasaki S., Maus U.A. Overexpression of Macrophage-Inducible C-Type Lectin Mincle Aggravates Proinflammatory Responses to Streptococcus pneumoniae with Fatal Outcome in Mice. J. Immunol., 2020, Vol. 205. no. 12, pp. 3390-3399.
32. Kale S.D., Dikshit N., Kumar P., Balamuralidhar V., Khameneh H.J,. Bin Abdul Malik N., Koh T.H., Tan G.G.Y., Tan T.T., Mortellaro A., Sukumaran B. Nod2 is required for the early innate immune clearance of Acinetobacter baumannii from the lungs. Sci. Rep., 2017, Vol. 7, no. 1, 17429. doi: 10.1038/s41598-017-17653-y.
33. Karnaushkina M.A., Guryev A.S., Mironov K.O., Dunaeva E.A., Korchagin V.I., Bobkova O.Y., Vasilyeva I.S., Kassina D.V., Litvinova M.M. Associations of Toll-like Receptor Gene Polymorphisms with NETosis Activity as Prognostic Criteria for the Severity of Pneumonia. Sovrem. Tekhnologii Med., 2021, Vol. 13, no. 3, pp. 47-53.
34. Kawai T., Ikegawa M., Ori D., Akira S. Decoding Toll-like receptors: Recent insights and perspectives in innate immunity. Immunity, 2024, Vol. 57, no. 4, pp. 649-673.
35. van Kempen G., Meijvis S., Endeman H., Vlaminckx B., Meek B., de Jong B., Rijkers G., Bos W.J. Mannosebinding lectin and l-ficolin polymorphisms in patients with community-acquired pneumonia caused by intracellular pathogens. Immunology, 2017, Vol. 151, no. 1, pp. 81-88.
36. Kobayashi T., Kuronuma K., Saito A., Ikeda K., Ariki S., Saitou A., Otsuka M., Chiba H., Takahashi S., Takahashi M., Takahashi H. Insufficient serum L-ficolin is associated with disease presence and extent of pulmonary Mycobacterium avium complex disease. Respir. Res., 2019, Vol. 20, no. 1, 224. doi: 10.1186/s12931-019-1185-9.
37. Korkmaz F.T., Shenoy A.T., Symer E.M., Baird L.A., Odom C.V., Arafa E.I., Dimbo E.L., Na E., MolinaArocho W., Brudner M., Standiford T.J., Mehta J.L., Sawamura T., Jones M.R., Mizgerd J.P., Traber K.E., Quinton L.J. Lectin-like oxidized low-density lipoprotein receptor 1 attenuates pneumonia-induced lung injury. JCI Insight, 2022, Vol. 7, no. 23, e149955. doi: 10.1172/jci.insight.149955.
38. Kottom T.J., Hebrink D.M., Jenson P.E., Marsolek P.L., Wüthrich M., Wang H., Klein B., Yamasaki S., Limper A.H. Dectin-2 Is a C-Type Lectin Receptor that Recognizes Pneumocystis and Participates in Innate Immune Responses. Am. J. Respir. Cell Mol. Biol., 2018, Vol. 58, no. 2, pp. 232-240.
39. Li D., Wu M. Pattern recognition receptors in health and diseases. Signal Transduct. Target Ther., 2021, Vol. 6, no. 1, 291. doi: 10.1038/s41392-021-00687-0.
40. Luo Q., He X., Ning P., Zheng Y., Yang D., Xu Y., Shang Y., Gao Z. Admission Pentraxin-3 Level Predicts Severity of Community-Acquired Pneumonia Independently of Etiology. Proteomics Clin. Appl., 2019, Vol. 13, no. 4, 1800117. doi: 10.1002/prca.201800117.
41. Lupfer C.R., Anand P.K., Qi X., Zaki H. Editorial: Role of NOD-Like Receptors in Infectious and Immunological Diseases. Front. Immunol., 2020, no. 11, 923. doi: 10.3389/fimmu.2020.00923.
42. Ma L., Li D., Wen Y., Shi D. Advances in understanding the role of pentraxin-3 in lung infections. Front. Immunol., 2025, no. 16, 1575968. doi: 10.3389/fimmu.2025.1575968.
43. Olonisakin T.F., Li H., Xiong Z., Kochman E.J., Yu M., Qu Y., Hulver M., Kolls J.K., St Croix C., Doi Y., Nguyen M.H., Shanks R.M., Mallampalli R.K., Kagan V.E., Ray A., Silverstein R.L., Ray P., Lee J.S. CD36 Provides Host Protection Against Klebsiella pneumoniae Intrapulmonary Infection by Enhancing Lipopolysaccharide Responsiveness and Macrophage Phagocytosis. J. Infect. Dis., 2016, Vol. 214, no. 12, pp. 1865-1875.
44. Pan Q., Chen H., Wang F., Jeza V.T., Hou W., Zhao Y., Xiang T., Zhu Y., Endo Y., Fujita T., Zhang X.L. L-ficolin binds to the glycoproteins hemagglutinin and neuraminidase and inhibits influenza A virus infection both in vitro and in vivo. J. Innate Immun., 2012, Vol. 4, no. 3, pp. 312-324.
45. Poeck H., Bscheider M., Gross O., Finger K., Roth S., Rebsamen M., Hannesschläger N., Schlee M., Rothenfusser S., Barchet W., Kato H., Akira S., Inoue S., Endres S., Peschel C., Hartmann G., Hornung V., Ruland J. Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1 beta production. Nat. Immunol., 2010, Vol. 11, no. 1, pp. 63-69.
46. Saijo S., Fujikado N., Furuta T., Chung S.H., Kotaki H., Seki K., Sudo K., Akira S., Adachi Y., Ohno N., Kinjo T., Nakamura K., Kawakami K., Iwakura Y. Dectin-1 is required for host defense against Pneumocystis carinii but not against Candida albicans. Nat. Immunol., 2007, Vol. 8, no. 1, pp. 39-46.
47. Shi G.Q., Yang L., Shan L.Y., Yin L.Z., Jiang W., Tian H.T., Yang D.D. Investigation of the clinical significance of detecting PTX3 for community-acquired pneumonia. Eur. Rev. Med. Pharmacol. Sci., 2020, Vol. 24, no. 16, pp. 8477-8482.
48. Shimada K., Chen S., Dempsey P.W., Sorrentino R., Alsabeh R., Slepenkin A.V., Peterson E., Doherty T.M., Underhill D., Crother T.R., Arditi M. The NOD/RIP2 pathway is essential for host defenses against Chlamydophila pneumoniae lung infection. PLoS Pathog., 2009, Vol. 5, no. 4, e1000379. doi: 10.1371/journal.ppat.1000379.
49. Siljan W.W., Holter J.C., Nymo S.H., Husebye E., Ueland T., Skattum L., Bosnes V., Garred P., Frøland S.S., Mollnes T.E., Aukrust P., Heggelund L. Low Levels of Immunoglobulins and Mannose-Binding Lectin Are Not Associated With Etiology, Severity, or Outcome in Community-Acquired Pneumonia. Open Forum Infect. Dis., 2018, Vol. 5, no. 2, ofy002. doi: 10.1093/ofid/ofy002.
50. Spoorenberg S.M., Vestjens S.M., Rijkers G.T., Meek B., van Moorsel C.H., Grutters J.C., Bos W.J. YKL40, CCL18 and SP-D predict mortality in patients hospitalized with community-acquired pneumonia. Respirology, 2017, Vol. 22, no. 3, pp. 542-550.
51. Świerzko A.S., Cedzyński M. The Influence of the Lectin Pathway of Complement Activation on Infections of the Respiratory System. Front. Immunol., 2020, no. 11, 585243. doi: 10.3389/fimmu.2020.585243.
52. Taban Q., Mumtaz P.T., Masoodi K.Z., Haq E., Ahmad S.M. Scavenger receptors in host defense: from functional aspects to mode of action. Cell Commun. Signal, 2022, Vol. 20, no. 1, 2. doi: 10.1186/s12964-021-00812-0
53. Taras R., Capitanescu G., Ionescu M., Cinteza E., Balgradean M. The prognostic value of mannose-binding lectin in community-acquired pneumonia. Maedica (Bucur.), 2020, Vol. 15, no. 1, pp. 11-17.
54. Tsuchiya K., Suzuki Y., Yoshimura K., Yasui H., Karayama M., Hozumi H., Furuhashi K., Enomoto N., Fujisawa T., Nakamura Y., Inui N., Yokomura K., Suda T. Author correction: macrophage mannose receptor CD206 predicts prognosis in community-acquired pneumonia. Sci. Rep., 2020, Vol. 10, no. 1, 3324. doi: 10.1038/s41598-020-58958-9.
55. Wang Z., Wang X., Zou H., Dai Z., Feng S., Zhang M., Xiao G., Liu Z., Cheng Q. The basic characteristics of the pentraxin family and their functions in tumor progression. Front. Immunol, 2020, no. 11, 1757. doi: 10.3389/fimmu.2020.01757.
56. Xiao X., Fu Y., You W., Huang C., Zeng F., Gu X., Sun X., Li J., Zhang Q., Du W., Cheng G., Liu Z., Liu L. Inhibition of the RLR signaling pathway by SARS-CoV-2 ORF7b is mediated by MAVS and abrogated by ORF7bhomologous interfering peptide. J. Virol., 2024, Vol. 98, no. 5, e0157323. doi: 10.1128/jvi.01573-23.
57. Xuan S., Ma Y., Zhou H., Gu S., Yao X., Zeng X. The implication of dendritic cells in lung diseases: Immunological role of toll-like receptor 4. Genes Dis., 2023, Vol. 11, no. 6, 101007. doi: 10.1016/j.gendis.2023.04.036.
58. Yoneyama M., Kato H., Fujita T. Physiological functions of RIG-I-like receptors. Immunity, 2024, Vol. 57, no. 4, pp. 731-751.
59. Zhao M., Tan X., Wu X.. The Role of ficolins in lung injury. J. Innate Immun., 2024, Vol. 16, no. 1, pp. 440-450.
60. Zhu L., Qi Z., Zhang H., Wang N. Nucleic acid sensor-mediated PANoptosis in viral infection. Viruses, 2024, Vol. 16, no. 6, pp. 966.
Supplementary files
|
1. 3328 | |
| Subject | ||
| Type | Other | |
Download
(7MB)
|
Indexing metadata ▾ | |
Review
For citations:
Zolotov M.O., Migacheva N.B., Lyamin A.V. Pattern recognition receptors and their role in immunopathogenesis of pneumonia. Medical Immunology (Russia). 2026;28(2):241-252. (In Russ.) https://doi.org/10.15789/1563-0625-PRR-3328
JATS XML





































